An anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A...
Up To Date
Latest News
GI specialist Ironwood Pharmaceuticals Inc. has announced to acquire Swiss VectivBio Holding AG for $17 per...
A new machine learning model can predict enzyme-substrate pairs, with an accuracy of over 90% and is ready to...
Carbon-capture specialist LanzaTech Global and Plastipak Packaging Inc have produced the world’s first PET...
Roche's bruton’s tyrosine kinas blocker fenebrutinib has met all endpoints in proof-of-concept study with...
uniQure N.V. is to sell a portion of its royalty rights from the net sales of its hemophilia B gene therapy...
Share
